Cite

HARVARD Citation

    Ibrahim, E. et al. (n.d.). Long-term rifaximin therapy as a primary prevention of hepatorenal syndrome. European journal of gastroenterology & hepatology. 29 (11), p. . [Online]. 
  
Back to record